BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• 

  ALS

  Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal

  The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral sclerosis, coming less than a year after the pharma licensed QurAlis’ antisense oligonucleotide to correct a specific protein alteration in ALS.

  May 6, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Earnings

  Vertex Shrugs Off Q1 Miss With ‘Strong’ Journavx Launch, Encouraging Pipeline Position

  Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big PBMs to cover the non-opioid pain drug.

  May 6, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  Trump Orders FDA To Ease US Plant Expansion; Drops Hammer on Foreign Inspections

  A new executive order from President Donald Trump aims to cut down the 5-to-10-year timeline to build new facilities while stepping up the rigor of inspections on foreign plants.

  May 6, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  VC Financings Drop 20% in Q1 but Megarounds Keep Median Deal Size High

  Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first three months of this year, headlined by a clutch of massive funding rounds.

  May 6, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• 

  Manufacturing

  BMS Pledges $40B Investment in US Despite Cost-Cutting Plans

  In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing investments in the U.S., including Eli Lilly, Johnson & Johnson and Novartis. BMS is the latest to make a multibillion-dollar push.

  May 6, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  FDA

  Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER

  The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and the accelerated approval of cancer drugs.

  May 6, 2025

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Legal

  States Sue RFK Jr., Makary, Seeking To Block HHS Cuts

  Twenty attorneys general allege that the recent workforce reduction at the Department of Health and Human Services is unlawful and could have potentially irreversible consequences.

  May 6, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Certara Reports First Quarter 2025 Financial Results

  May 6, 2025

   · 

  23 min read
• Press Releases

  Castle Biosciences Reports First Quarter 2025 Results

  May 6, 2025

   · 

  27 min read
• Press Releases

  Castle Biosciences to Acquire Previse

  May 6, 2025

   · 

  4 min read